Resources Contact Us Home
Pharmaceutical compositions and preparations for treatment of metabolic bone disease

Image Number 4 for United States Patent #6835722.

The present invention relates to a pharmaceutical composition for the treatment of metabolic bone disease and the method of preparation thereof, and more particularly, to an improved pharmaceutical composition for the therapeutic treatment of metabolic disease and the method of preparation thereof, wherein said composition is prepared as a composite pharmaceutical agent which comprises calcitriol; which reduces the rate of spine fractures and increases bone density; alendronate, a bone resorption inhibitor, as two main active ingredients in an optimal mixing ratio to exert the greatest synergistic therapeutic effect; and adequate amount of other additives such as a resorption fortifier of alendronate. Thereof, the pharmaceutical composition according to the present invention can inhibit hypercalcemia caused when administered by calcitriol alone, compensate the inhibitory activity of bone remodeling caused by alendronate due to the presence of calcitriol, and improve drug compliance associated with the usual difficulty in administration as well as a side effect in esophagus, thus effectively preventing the occurence of osteoporosis.

  Recently Added Patents
Liquid crystal display
Reduced sorbent utilization for circulating dry scrubbers
Semiconductor memory device
Information distribution system, information distributing method, node, and recording medium
System and method for a driver circuit with a referenced control signal
Electronic device package and fabrication method thereof
Solution based precursors
  Randomly Featured Patents
Spinal stabilization method
Tray and retainer combination
Quick connector for piping
Methods of treating headache and functional extraocular and intraocular myotendinitis
Twist lock mechanism for a tape measure
Self-aligning pinch roll for magnetic card transport system
Building construction
Hydrogel seton
Process for preparing alkyl substituted para-carboalkoxy cyclohexanones